| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/17/2003 | EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 12/17/2003 | EP1370526A1 Diamides which inhibit tryptase and factor xa activity |
| 12/17/2003 | EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists |
| 12/17/2003 | EP1370518A2 Tryptase-inhibitors |
| 12/17/2003 | EP1370297A2 Method and composition |
| 12/17/2003 | EP1370290A2 Molecular antigen array |
| 12/17/2003 | EP1370289A2 Method for producing a vaccine containing autologous antibodies |
| 12/17/2003 | EP1370286A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 12/17/2003 | EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 12/17/2003 | EP1370278A1 Immunomodulatory properties of bip |
| 12/17/2003 | EP1370276A2 Medical uses of intercellular communication facilitating compounds |
| 12/17/2003 | EP1370251A1 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 12/17/2003 | EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 12/17/2003 | EP1206467B1 N-heterocyclic derivatives as nos inhibitors |
| 12/17/2003 | EP1189889B1 Compositions and methods for inhibiting cell death |
| 12/17/2003 | EP1162970B1 Anti-inflammatory uses of manzamines |
| 12/17/2003 | EP1082302B1 A vla-4 inhibitor: omepupa-v |
| 12/17/2003 | EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils |
| 12/17/2003 | EP0900212B1 Chiral phenyldihydrofuranones as pde-iv inhibitors |
| 12/17/2003 | EP0831820B1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 12/17/2003 | EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 12/17/2003 | EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor |
| 12/17/2003 | CN1462270A Imidazole derivatives or their salts |
| 12/17/2003 | CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 12/17/2003 | CN1131314C Recombination eukaryotic carrier containing sensitinogen gene and application thereof |
| 12/17/2003 | CN1131309C IL-6 mutein |
| 12/17/2003 | CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis |
| 12/16/2003 | US6664406 Fatty acid esters used as antiinflammatory or immunomodulatory agents |
| 12/16/2003 | US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia |
| 12/16/2003 | US6664265 Imidazo(4,5-c)quinoline-4-amines; inducing cytokine biosynthesis; viral and neoplastic disease treatment |
| 12/16/2003 | US6664264 Thioether substituted imidazoquinolines |
| 12/16/2003 | US6664260 Heterocyclic ether substituted imidazoquinolines |
| 12/16/2003 | US6664253 Neurokinin antagonists |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/16/2003 | US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents |
| 12/16/2003 | US6664230 Orally administered peptides to ameliorate atherosclerosis |
| 12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 12/16/2003 | US6663878 Anti-inflammatory bioactive glass particulates |
| 12/16/2003 | US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria |
| 12/16/2003 | US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid |
| 12/16/2003 | US6663859 Compositions for enhancing the immune response |
| 12/16/2003 | CA2286879C Novel method for the production of anti-human antigen receptors and uses thereof |
| 12/14/2003 | CA2430259A1 Vaccine |
| 12/11/2003 | WO2003102237A1 Treatment with cytokines |
| 12/11/2003 | WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 12/11/2003 | WO2003102189A1 Allergen from mugwort pollen |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102183A1 Pramyxovirus vectors encoding antibody and utilization thereof |
| 12/11/2003 | WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 12/11/2003 | WO2003101989A1 Inhibitors of jak and cdk2 protein kinases |
| 12/11/2003 | WO2003101987A1 3-substituted quinuclidines and their use |
| 12/11/2003 | WO2003101981A1 Novel substituted indoles |
| 12/11/2003 | WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 12/11/2003 | WO2003101970A1 Imidazolium cxcr3 inhibitors |
| 12/11/2003 | WO2003101968A1 Pyrazole compound and medicinal composition containing the same |
| 12/11/2003 | WO2003101964A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 12/11/2003 | WO2003101951A2 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders |
| 12/11/2003 | WO2003101468A1 Method for the protection of endothelial and epithelial cells during chemotherapy |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101464A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 12/11/2003 | WO2003101460A1 External preparations for treating dermatitis |
| 12/11/2003 | WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 12/11/2003 | WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/11/2003 | WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 12/11/2003 | WO2003080566A3 Hif hydroxylase inhibitors |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003048206A3 Growth hormone agonist peptides and their uses |
| 12/11/2003 | WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/11/2003 | WO2003027090A3 Bicyclic heterocycles as rxr ligands |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003025012A3 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 12/11/2003 | WO2003024395A3 Linked biaryl compounds |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003022883A3 Use of proteins for the production of a medicament for stimulating the innate non specific immune system |
| 12/11/2003 | WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003004460A3 Succinic acid derivatives |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000241A3 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002053149A3 Medicament containing a polyamine as an active substance |
| 12/11/2003 | WO2002048165A8 Antiviral agents for treatment of flaviviridae infections |
| 12/11/2003 | WO2002043758A3 Uses of mammalian genes and related reagents |
| 12/11/2003 | US20030229208 Humanized immunoglobulins |
| 12/11/2003 | US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 12/11/2003 | US20030229116 Enamine derivatives |
| 12/11/2003 | US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants |
| 12/11/2003 | US20030229110 Cell signal transduction |
| 12/11/2003 | US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization |
| 12/11/2003 | US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | US20030229048 Skin disorders; antiinflammatory agents |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |